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Objective : Moyamoya disease (MMD) is an uncommon cerebrovascular disorder, characterized by progressive occlusion at the terminal portion
of the internal carotid artery. Incidence of the disease is high in East Asia and familial MMD accounts for about 15% of the disease. Although the
pathogenesis is unknown, association of HLA class I or II alleles with MMD has been reported with conflicting results. We investigated whether
there is a difference in HLA class II association between familial and non-familial forms of the disease. 
Methods : A total of 70 Korean children with MMD, including 16 familial cases (10 probands), and 207 healthy controls were studied. Among
familial cases, only 10 probands were used for the HLA frequency analysis. High resolution HLA-DRB1 and DQB1 genotyping was performed
using polymerase chain reaction (PCR)-sequence specific oligonucleotide hybridization and PCR-single strand conformation polymorphism
methods. 
Results : The phenotype frequencies of HLA-DRB1*1302 (70.0%) and DQB1*0609 (40.0%) were significantly increased in familial MMD
compared to both controls [vs. 15.5%, corrected p (pc) = 0.008, odds ratio (OR) = 12.76; vs. 4.3%, pc = 0.02, OR = 14.67] and non-familial MMD
patients (vs. 14.8%, pc = 0.02, OR = 13.42; vs. 1.9%, pc = 0.02, OR = 35.33). The frequencies of DRB1 and DQB1 alleles in non-familial MMD
patients were not significantly different from those in controls.
Conclusion : Our findings suggest that the genetic polymorphism of HLA class II genes or other closely linked disease relevant gene(s) could be
a genetic predisposing factor for familial MMD. 
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INTRODUCTION
Moyamoya disease (MMD) is an uncommon cerebro-
vascular disorder that is characterized by progressive steno-
occlusive lesions of the terminal portion of the internal
carotid artery and its main branches within the circle of
Willis. This occlusion results in the formation of a fine
vascular network of collateral circulation, the moyamoya
vessels (“moyamoya” means “puff of smoke” in Japanese) at
the base of the brain, as shown by cerebral angiography18).
Definite cases of MMD are diagnosed in patients with
bilateral lesions, whereas patients with unilateral lesions are
diagnosed as probable cases5). The incidence of MMD is
high in countries in East Asia, such as Korea and Japan,
although worldwide distribution of the disease has been
reported with much lower incidences7,18). The disease is
distributed in all age groups, but the highest peak is in
childhood at less than 10 years of age with a second low
peak from 30s to 40s6,30).  
The pathogenesis of MMD is still unclear18). Several
pieces of evidence suggest the involvement of genetic factors
in MMD : 1) over 10% of MMD patients have affected
blood relatives, 2) concordance in the affection status has
been proven in 80% of identical twins, and 3) there is an
ethnic predisposition to MMD, the incidence of the disease
being the highest in the Asian population9). Data from an
epidemiological study of familial MMD have suggested
that MMD is probably inherited in a polygenic or autosomal
dominant mode with a low penetrance21). Microsatellite
linkage analysis has identified genetic loci that are associ-
ated with MMD on chromosomes 3, 6, 8, and 1711,13,20,26,32).
However, the relevant genes have not been identified so
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far18,20). 
In relation to genetic factors associated with the disease,
associations of various HLA class I or class II alleles with
the disease have been reported in Japanese2,12,14,17) and
Koreans8) with conflicting results. Although familial forms
account 10-15% of MMD patients6,18,31), HLA association
with the disease has not been studied separately in familial
and non-familial (sporadic) MMD cases. Thus, it is not
known whether there is a difference between these two
forms of the disease with regard to HLA association. We
have studied HLA association with the disease in 70 Korean
children including 16 familial cases, and found a strong
association of HLA-DR and -DQ genes with the disease in
the familial form of the disease. 
MATERIALS AND METHODS 
Patients and controls
A total of 70 patients, who were diagnosed as having
MMD after cerebral angiography at Seoul National Univer-
sity Children’s Hospital between 2001 and 2004 were
included in this study. The patients comprised of 29 boys
and 41 girls. Fifty-four patients were sporadic (non-familial)
cases and did not have other affected family members.
Sixteen (22.9%) of the 70 patients had more than one
family member diagnosed as MMD (familial MMD).
They were from 10 family pedigrees (6 pairs of family
members from 6 families and 4 single patients from 4
families) including 10 proband cases. Thirteen patients had
first-degree (one in mother, 12 in siblings including 4
identical twins) and three had third-degree family members
(cousins) affected. Age distribution was 7.1 ± 2.7 (SD)
(range 7 months-12 years) in total patients; 7.5 ± 2.6 (7
months-12 years) in non-familial cases; and 5.9 ± 2.9 (13
months-10 years) in familial cases. Female to male ratio was
1.4 (41 : 29) in total patients; 1.2 (29 : 25) in non-familial
cases; and 3.0 (12 : 4) in familial cases. Informed consent
was obtained from each patient to acquire peripheral blood
for genetic study. All the patients were of Korean ethnicity.
Control group consisted of 207 healthy Koreans from our
previous study, who were unrelated parents of 107 families
recruited for family study of HLA polymorphism in this
population28).
HLA-DR and -DQ typing
Genomic DNA was extracted from the peripheral blood
using LaboPassTM Blood kit (CosmoGenetech, Seoul,
Korea). HLA-DRB1 typing was performed in two steps.
Intermediate-resolution HLA-DRB typing was carried out
by the PCR-SSO (sequence specific oligonucleotide) hybri-
dization method using the Dynal RELITM SSO HLA-DRB
Test (Dyanl Biotech Ltd., Wirral, UK). For high-resolution
HLA-DRB1 typing, group-specific amplifications and
PCR-SSCP (single strand conformation polymorphism)
analysis was performed as described3) with minor modifi-
cations. HLA-DQB1 typing was also performed in two
steps. Intermediate-resolution HLA-DQB1 typing was
carried out by the PCR-SSO method using the Dynal
RELITM SSO HLA-DQB1 Test (Dyanl Biotech). For high-
resolution HLA-DQB1 typing, group specific amplifications
and PCR-SSCP was performed as described23).  
Statistical analysis
The phenotype frequencies of HLA-DRB1 and -DQB1
alleles were compared using Fisher’s exact test (2-tail). Am-
ong 16 familial cases, only 10 proband cases were included
in the frequency analysis. The level of significance was set at
p < 0.05, and odds ratios (OR) with 95% confidence inter-
vals (CI) were calculated for those comparisons demonstra-
ting significant p values. Where indicated as corrected p
(pc), a Bonferroni correction was applied by multiplying the
probability value by the number of comparisons made (27
for DRB1 and 15 for DQB1 alleles). SPSS for Windows
version 12.0 (SPSS Inc., Chicago, IL, USA) was used for
statistical analysis. 
RESULTS
Phenotype frequencies of HLA-DRB1 alleles in MMD
patients are presented in Table 1. Frequencies of HLA-
DRB1 alleles were not significantly different between total
MMD patients and controls. When the MMD patients of
familial and non-familial cases were analyzed separately,
familial MMD showed markedly increased frequency of
DRB1*1302 (70%) compared to both controls (15.5%, p
= 0.0003, pc = 0.008, OR = 12.76) and non-familial MMD
(14.8%, p = 0.0008, pc = 0.02, OR = 13.42). However, the
frequencies of DRB1 alleles in non-familial MMD were
quite similar to those of controls, and no significant differ-
ence was observed. 
Frequencies of HLA-DQB1 alleles were not significantly
different between total MMD patients and controls (Table
2). However, familial MMD patients showed significantly
increased frequency of DQB1*0609 (40%) compared to
both controls (4.3%, p = 0.001, pc = 0.02, OR = 14.67) and
non-familial MMD (1.9%, p = 0.002, pc = 0.02, OR =
35.33). DQB1*0502 was increased in familial MMD when
compared to non-familial MMD (20% vs. 0%, p = 0.02,
OR = incalculable). The frequencies of DQB1 alleles in
non-familial MMD were not significantly different from
those in controls. 
HLA-DRB1 and -DQB1 alleles and DRB1*1302-
DQB1*0609 haplotypes in 16 familial MMD cases, includ-
ing 10 proband cases are presented in Table 3. DRB1*1302
is exclusively associated with either DQB1*0604 or
DQB1*0609 in Koreans28). Seven of the 10 proband cases
carried DRB1*1302 allele, among which 3 and 4 were
associated with DQB1*0604 and DQB1*0609, respec-
tively. One patient was homozygous for the DRB1*1302-
DQB1*0609 haplotype. Familial MMD patients showed
significantly increased haplotype frequency of DRB1*1302-
DQB1*0609 (25.0%) compared to both controls (2.4%, p
= 0.0003, OR = 13.47) and non-familial MMD (0.9%, p
= 0.0003, OR = 35.67). Although the haplotype frequency
of DRB1*1302-DQB1*0604 was slightly increased in
familial MMD patients compared to that of controls, it was
not statistically significant (15% vs. 6.5%, p = 0.15). 
DISCUSSION 
In our study, familial MMD patients
showed markedly increased frequency
of HLA-DRB1*1302 allele (pheno-
type frequency of 70%) compared to
both controls (15.5%, pc = 0.008, OR
= 12.76) and non-familial MMD pati-
ents (14.8%, pc = 0.02, OR = 13.42)
(Table 1). Among the two HLA-
DQB1 alleles (DQB1*0604 and
*0609) tightly linked with DRB1*
1302 in Koreans28), DQB1*0609 was
significantly increased in familial
MMD patients compared to both
controls (pc = 0.02, OR = 14.67) and
non-familial MMD patients (pc = 0.02,
OR = 35.33) (Table 2). Thus, the
haplotype frequency of DRB1*1302-
DQB1*0609 was significantly inc-
reased in familial MMD patients com-
pared to both controls (p = 0.0003,
OR = 13.47) and non-familial MMD
(p = 0.0003, OR = 35.67) (Table 3). In
contrast, non-familial MMD patients
did not show any significant change
in the frequencies of HLA-DRB1 or
DQB1 alleles compared to controls. 
The strong association of HLA-
DRB1*1302 and DQB1*0609 alleles
with familial MMD patients observed
in the present study of Koreans is
much stronger than those reported to
date in Japanese or Korean MMD patients2,8,12,14,17). Previous
studies included relatively small number of patients, and
the investigators did not attempt to analyze the HLA asso-
ciation with familial and non-familial MMD, separately.
Various HLA class I antigens were reported to be associated
with MMD in three different studies of Japanese and
Korean MMD patients. Increased frequencies of HLA-
A24, B46, B51, B54, and B67 in Japanese2,17) and B35 in
Korean MMD patients8) were reported. However, the asso-
ciations were rather weak (p values in the range of < 0.05 -
< 0.005; 18-32 patients studied) and none of the HLA
class I antigens has been corroborated by more than one
report. 
There have been studies on the investigation of HLA
class II association with the disease in Japanese, which also
revealed non-concordant results. Aoyagi et al.2) reported
weak association of DR1 [relative risk (RR) 9.1, p < 0.05] by
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Table 1. Phenotype frequencies of HLA-DRB1 alleles in Korean patients with moyamoya disease
(MMD)  
Controls Total MMD Familial MMD Non-familial MMD 
HLA-DRB1* (n = 207) (n = 64)* (n = 10)* (n = 54)
No.  (%) No. (%) No. (%) No. (%)
0101 29 (14.0) 12 (18.8) 2 (20.0) 10 (18.5)
0301 7 (3.4) 3 (4.7) 0 (0.0) 3 (5.6)
0403 10 (4.8) 3 (4.7) 1 (10.0) 2 (3.7)
0404 4 (1.9) 1 (1.6) 0 (0.0) 1 (1.9)
0405 33 (15.9) 9 (14.1) 2 (20.0) 7 (13.0)
0406 22 (10.6) 4 (6.3) 0 (0.0) 4 (7.4)
0407 2 (1.0) 1 (1.6) 0 (0.0) 1 (1.9)
0410 5 (2.4) 2 (3.1) 0 (0.0) 2 (3.7)
0701 27 (13.0) 7 (10.9) 0 (0.0) 7 (13.0)
0802 12 (5.8) 4 (6.3) 1 (10.0) 3 (5.6)
0803 31 (15.0) 10 (15.6) 1 (10.0) 9 (16.7)
0901 33 (15.9) 13 (20.3) 0 (0.0) 13 (24.1)
1001 9 (4.3) 1 (1.6) 1 (10.0) 0 (0.0)
1101 14 (6.8) 6 (9.4) 0 (0.0) 6 (11.1)
1201 20 (9.7) 4 (6.3) 0 (0.0) 4 (7.4)
1202 19 (9.2) 3 (4.7) 0 (0.0) 3 (5.6)
1301 6 (2.9) 4 (6.3) 0 (0.0) 4 (7.4)
1302 32 (15.5) 15 (23.4) 7 (70.0)�� 8 (14.8) 
1401 14 (6.8) 4 (6.3) 2 (20.0) 2 (3.7)
1402 2 (1.0) 0 (0.0) 0 (0.0) 0 (0.0)
1403 5 (2.4) 0 (0.0) 0 (0.0) 0 (0.0)
1405 16 (7.7) 4 (6.3) 1 (10.0) 3 (5.6)
1406 0 (0.0) 1 (1.6) 0 (0.0) 1 (1.9)
1407 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0)
1501 35 (16.9) 6 (9.4) 0 (0.0) 6 (11.1)
1502 9 (4.3) 4 (6.3) 0 (0.0) 4 (7.4)
1602 0 (0.0) 1 (1.6) 1 (10.0) 0 (0.0)
*Among 16 familial cases, 10 proband cases were included in the analysis,�p= 0.0003, pc (corrected 
p) = 0.008. OR = 12.76 (3.13-51.95) vs. controls,�p = 0.0008, pc = 0.02, OR = 13.42 (2.86-63.02) vs. non-
familial MMD
serological typing. Inoue et al.14) studied HLA-DR and -
DQ associations in MMD patients by molecular typing
and found different alleles associated with early-onset
(onset ≤ 10 years of age) and late-onset (onset > 10 years of
age) MMD. HLA-DRB1*1501 (RR 2.3) and DQB1*0602
(RR 2.42) were increased and DRB1*0405 was decreased
(RR 0.38) in early-onset, whereas DQB1*0502 was increas-
ed (RR 4.72) in late-onset MMD patients. The associations
were weak (p values in the range of <
0.05 - < 0.025) and none of the asso-
ciations was significant after Bonfer-
roni correction. In our study, although
majority (57/64, 89%) of the patients
belonged to the early-onset MMD
including 10 familial cases, we could
not find those associations reported in
the Japanese patients with early-onset
MMD. 
When particular HLA alleles are
associated with disease susceptibility
or resistance, there are two possible
mechanisms of association. These
HLA alleles may directly control the
susceptibility to or resistance against
the disease. Another possibility is that
these HLA alleles are simply disease
associated markers, showing linkage
disequilibrium with other disease rele-
vant genes located close to the HLA
genes. The latter is more likely in
MMD, because thus far reported HLA
alleles associated with the disease quite
vary among different studies. Then
questions arise what would be the di-
sease relevant gene(s) closely linked
with DRB1*1302-DQB1*0609 haplo-
type in Korean patients with familial
MMD. One of the possibilities is the
tumor necrosis factor (TNF)-α gene
considering the TNF-α promoter
polymorphisms and extended HLA
and TNF-α haplotypes in Koreans24).
TNF-α high producer haplotype con-
taining -308A allele in the promoter
region of the TNF-α gene is strongly
linked with HLA-A33, B58, and
DRB1*1302 alleles24), which are in
strong linkage disequilibrium with
DQB1*0609 allele28). However, change
in the TNF-α level or genetic poly-
morphism of TNF-α gene has not been investigated in
MMD patients to date.
Pathological findings in the carotid terminations of cere-
bral arteries in MMD patients show fibrocellular thickening
of the intima, irregular undulation (waving) of the internal
elastic lamina, and attenuation of the media18). Although
we have no definite explanation for the pathogenesis of
MMD, the final common pathway seems to involve proli-
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Table 2. Phenotype frequencies of HLA-DQB1 alleles in Korean patients with moyamoya disease
(MMD) 
Controls Total MMD Familial MMD Non-familial MMD 
HLA-DQB1* (n = 207) (n = 64)* (n = 10)* (n = 54) 
No. (%) No. (%) No. (%) No. (%)
0201 7 (3.4) 3 (4.7) 0 (0.0) 3 (5.6)
0202 25 (12.1) 7 (10.9) 0 (0.0) 7 (13.0)
0301 55 (26.6) 13 (20.3) 0 (0.0) 13 (24.1)
0302 40 (19.3) 11 (17.2) 2 (20.0) 9 (16.7)
0303 41 (19.8) 15 (23.4) 0 (0.0) 15 (27.8)
0401 32 (15.5) 9 (14.1) 2 (20.0) 7 (13.0)
0402 14 (6.8) 4 (6.3) 0 (0.0) 4 (7.4)
0501 38 (18.4) 15 (23.4) 3 (30.0) 12 (22.2)
0502 8 (3.9) 2 (3.1) 2 (20.0)� 0 (0.0)
0503 22 (10.6) 6 (9.4) 2 (20.0) 4 (7.4)
0601 33 (15.9) 12 (18.8) 1 (10.0) 11 (20.4)
0602 34 (16.4) 6 (9.4) 0 (0.0) 6 (11.1)
0603 7 (3.4) 4 (6.3) 0 (0.0) 4 (7.4)
0604 25 (12.1) 10 (15.6) 3 (30.0) 7 (13.0)
0609 9 (4.3) 5 (7.8) 4 (40.0)�§ 1 (1.9)
*Among 16 familial cases, 10 proband cases were included in the analysis,�p = 0.02 (OR = incalculable) 
vs. non-familial MMD,�p = 0.001, pc (corrected p) = 0.02, OR = 14.67 (3.51-61.33) vs. controls, §p = 0.002, pc
= 0.02. OR = 35.33 (3.38-369.86) vs non-familial MMD
Table 3. HLA-DRB1 and -DQB1 alleles and DRB1*1302-DQB1*0609 haplotypes in 16 familial
cases of moyamoya disease (MMD) including 10 proband cases  
Case No.
Sex / Age 
DRB1* DRB1* DQB1* DQB1*
Affected family 
(years) members
F01* F/6 1302 1401 0503 0604 Twin (F02)
F02 F/6 1302 1401 0503 0604 Twin (F01)
F03* F/10 0405 1302 0401 0604 Twin (F04)
F04 F/10 0405 1302 0401 0604 Twin (F03)
F05* F/2 1302 0803 0601 0604 Sister (F06)
F06 F/6 1201 0802 0301 0402 Sister (F05)
F07*� F/5 1302 - 0609 - Sister (F08)
F08� F/3 1302 - 0609 - Sister (F07)
F09* F/5 0405 1001 0401 0501 Sister (F10)
F10 F/4 1202 1302 0301 0604 Sister (F09)
F11* M/7 0101 1401 0501 0502 Cousin (F12)
F12 F/8 0405 0901 0303 0401 Cousin (F11)
F13* M/1 0101 1405 0501 0503 Brother
F14* F/10 1602 1302 0502 0609 Mother
F15* M/3 0403 1302 0302 0609 Brother
F16* M/9 0802 1302 0302 0609 Cousin
*Proband cases, �Homozygous for DRB1*1302-DQB1*0609 haplotype. DRB1*1302-DQB1*0609 haplotype
(underlined) frequency in proband cases of familial MMD (25.0%, 5/20) : p = 0.0003, OR = 13.47 (4.09-
44.30) vs. controls (2.4%, 10/414); p = 0.0003, OR = 35.67 (3.90-326.43) vs. non-familial MMD (0.9%, 1/108) 
feration of smooth muscle cells and their migration from
the media to the intima1,16). This process is regulated by
various growth factors, and the results from previous studies
have shown that concentrations of certain growth factors or
cytokines are increased in the cerebrospinal fluid and/or
their expression is increased in the intracranial and extrac-
ranial arteries of patients with MMD18). These include
basic fibroblast growth factor10), soluble adhesion mole-
cules29), cellular retinoic-acid-binding protein I (CRABP-
I)16), and hepatocyte growth factor, an angiogenic protein22).
In vascular injury and repair, besides aforementioned various
growth factors, a balance between the activities of connective
tissue degrading enzymes, matrix metalloproteinases (MMPs)
and their endogenous inhibitors, tissue inhibitors of me-
talloproteinases (TIMPs) is important27), which might be
deranged in MMD. In this context, increased expression of
serum MMP-94) and genetic polymorphism of TIMP2
gene15) were reported to be associated with MMD. It is of
interest that the study of TIMP gene suggested a difference
in the genetic predisposition of familial and non-familial
MMD, as we have found in the present study of HLA gene.
Presence of a G/C heterozygous genotype at position -418
in TIMP2 promoter (located in chromosome 17q25), which
was expected to reduce the transcription of TIMP2, was
associated with familial, but not with non-familial MMD15).
We have found that HLA-DRB1*1302 and DQB1*0609
alleles were strongly associated with familial MMD in the
present study, and DRB1*1302-DQB1*0609 haplotype in
Koreans might be a predisposing factor for increased
intimal fibrosis and occlusion of cerebral arteries observed
in MMD patients. It is of interest that HLA-DRB1*1302
and DQB1*0609 alleles were significantly associated with
liver fibrosis following Schistosoma japonicum infection in
Southern Chinese, in whom these two HLA class II alleles
are in very strong linkage disequilibrium, forming a com-
mon haplotype19). In contrast, this haplotype is very rare in
Japanese25). We speculated that HLA-DRB1*1302 and
DQB1*0609 alleles associated with familial MMD might
be related with TNF-α gene polymorphism of high pro-
ducer type. Whether genetic polymorphism of TNF-α gene
is associated with the disease needs to be studied to get more
insight into the pathogenesis of the disease. 
CONCLUSION
We for the first time found a difference in the genetic
predisposition of familial and non-familial MMD in terms
of HLA association. HLA-DRB1*1302 and DQB1*0609
alleles were significantly associated with familial, but not
with non-familial form of the disease in Koreans. Our find-
ings suggest that the genetic polymorphism of HLA class II
genes or other closely linked disease relevant gene(s) could
be a genetic predisposing factor for familial MMD. 
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